DE69107932T2 - Stabile wässerige Zubereitung. - Google Patents

Stabile wässerige Zubereitung.

Info

Publication number
DE69107932T2
DE69107932T2 DE69107932T DE69107932T DE69107932T2 DE 69107932 T2 DE69107932 T2 DE 69107932T2 DE 69107932 T DE69107932 T DE 69107932T DE 69107932 T DE69107932 T DE 69107932T DE 69107932 T2 DE69107932 T2 DE 69107932T2
Authority
DE
Germany
Prior art keywords
acid
vitamin
stable
preparation
epsilon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69107932T
Other languages
English (en)
Other versions
DE69107932D1 (de
Inventor
Kazumichi Ushio
Kenichi Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16899290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69107932(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of DE69107932D1 publication Critical patent/DE69107932D1/de
Application granted granted Critical
Publication of DE69107932T2 publication Critical patent/DE69107932T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
DE69107932T 1990-08-30 1991-08-29 Stabile wässerige Zubereitung. Expired - Fee Related DE69107932T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22988890 1990-08-30

Publications (2)

Publication Number Publication Date
DE69107932D1 DE69107932D1 (de) 1995-04-13
DE69107932T2 true DE69107932T2 (de) 1995-07-27

Family

ID=16899290

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69107932T Expired - Fee Related DE69107932T2 (de) 1990-08-30 1991-08-29 Stabile wässerige Zubereitung.

Country Status (9)

Country Link
US (1) US5185372A (de)
EP (1) EP0473159B1 (de)
JP (1) JP3256997B2 (de)
AT (1) ATE119387T1 (de)
CA (1) CA2049822C (de)
DE (1) DE69107932T2 (de)
DK (1) DK0473159T3 (de)
ES (1) ES2069150T3 (de)
GR (1) GR3015340T3 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005012176A1 (de) * 2005-03-15 2006-09-28 Zarrin Anna Buchheim Gerät zur reinigenden Behandlung der Augenlider

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830508A (en) 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
TW252974B (de) * 1993-03-23 1995-08-01 Takeda Dharm Industry Co Ltd
US20020173547A1 (en) 1994-03-22 2002-11-21 Jones Christopher Buchan Pharmaceuticals compositions
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US5617602A (en) * 1995-06-27 1997-04-08 Okada; Eiji Motor-driven toothbrush
US5706542A (en) * 1995-06-27 1998-01-13 Okada; Eiji Electrically driven toothbrush
JPH09124484A (ja) * 1995-10-27 1997-05-13 Schering Purau Kk 点眼剤
DE69714081T2 (de) * 1997-04-25 2002-11-14 Schering Plough K K Augentropfen enthaltend ein loratidinmetabolit
BR9906597A (pt) * 1998-07-14 2000-07-18 Alcon Lab Inc Produto de prostaglandina
US6235781B1 (en) 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
US6291519B1 (en) 1998-10-14 2001-09-18 Novartis Ag Method of preventing damage to eye tissue
ATE341340T1 (de) * 1999-08-10 2006-10-15 Santen Pharmaceutical Co Ltd Zusammensetzungen zur eröffnung der wasserkanäle und medizinische zusammensetzungen zur opthalmischer verwendung
JP4880808B2 (ja) * 1999-11-15 2012-02-22 久光製薬株式会社 人工涙液型点眼剤組成物
AU2002212234A1 (en) * 2000-09-14 2002-03-26 Novartis Ag Stable ophthalmic preparation
JP4849288B2 (ja) * 2000-09-29 2012-01-11 ライオン株式会社 点眼剤及び涙液膜の安定化剤
US6774100B2 (en) 2000-12-06 2004-08-10 Imaginative Research Associates, Inc. Anhydrous creams, lotions and gels
US6462025B2 (en) 2000-12-12 2002-10-08 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US20060189552A1 (en) * 2000-12-12 2006-08-24 Mohan Vishnupad Dispenser for dispensing three or more actives
US7060732B2 (en) 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
WO2002049613A2 (en) * 2000-12-19 2002-06-27 Bausch & Lomb Incorporated Method for enhancing integrity of epithelium using retinoic acid
TW586946B (en) † 2000-12-22 2004-05-11 Novartis Ag Process to improve stability
DK1347787T4 (da) * 2001-01-09 2011-01-03 Louis Johan Wagenaar Anvendelse af dexpanthenol i kontaktlinse-plejesammensætninger
US20030165546A1 (en) * 2002-03-04 2003-09-04 The Procter & Gamble Company Stable personal care compositions containing a retinoid
US6984628B2 (en) 2003-07-15 2006-01-10 Allergan, Inc. Ophthalmic compositions comprising trefoil factor family peptides
DE10355715A1 (de) * 2003-11-26 2005-06-16 Beiersdorf Ag Wirkstoffkombinationen Kreatin und/oder Kreatinderivaten und/oder Kreatinin und/oder Kreatininderivaten und einer wirksamen Menge an Retinoiden, insbesondere Retinol bzw. Retinylpalmitat und Zubereitungen, solche Wirkstoffkombinationen enthaltend
US9161905B2 (en) * 2005-01-12 2015-10-20 Ocular Research Of Boston, Inc. Dry eye treatment
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
WO2008052037A2 (en) * 2006-10-24 2008-05-02 Alcon Research, Ltd. Packaging materials for formulations containing 2-pyrrolidone derivatives
US9034843B2 (en) * 2007-09-14 2015-05-19 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition
GB2471304B (en) 2009-06-24 2013-12-11 Oval Medical Technologies Ltd A pre-filled syringe or autoinjector
GB2471726B (en) 2009-07-10 2013-09-11 Oval Medical Technologies Ltd A pre-filled syringe including an oxygen absorber
JP5518608B2 (ja) * 2010-07-09 2014-06-11 ロート製薬株式会社 粘膜適用液状組成物
US20130281390A1 (en) * 2010-12-29 2013-10-24 Kurt E. Brubaker Method for treating dry eye
JP2012006962A (ja) * 2011-08-22 2012-01-12 Lion Corp 眼科用組成物
CN104136019A (zh) * 2012-02-27 2014-11-05 日本乐敦制药株式会社 眼科用组合物试剂盒
CN114502205A (zh) * 2019-08-18 2022-05-13 艾威药业公司 含稀聚维酮碘制剂的稳定药品

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199567A (en) * 1979-01-02 1980-04-22 Burton, Parsons & Company, Inc. Method for imparting freeze stability to chlorhexidine-containing medicaments
US5032392A (en) * 1986-09-04 1991-07-16 Vision Pharmaceuticals Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005012176A1 (de) * 2005-03-15 2006-09-28 Zarrin Anna Buchheim Gerät zur reinigenden Behandlung der Augenlider

Also Published As

Publication number Publication date
GR3015340T3 (en) 1995-06-30
EP0473159A1 (de) 1992-03-04
CA2049822A1 (en) 1992-03-01
DE69107932D1 (de) 1995-04-13
CA2049822C (en) 2001-07-24
ATE119387T1 (de) 1995-03-15
EP0473159B1 (de) 1995-03-08
DK0473159T3 (da) 1995-05-22
US5185372A (en) 1993-02-09
ES2069150T3 (es) 1995-05-01
JP3256997B2 (ja) 2002-02-18
JPH054918A (ja) 1993-01-14

Similar Documents

Publication Publication Date Title
DE69107932T2 (de) Stabile wässerige Zubereitung.
DE3569836D1 (en) Disinfecting method and compositions
ATE134377T1 (de) Stabile salze von 4''-desoxy-4''-epimethylamino- avermectin-bla/blb
DE69131145T2 (de) Reinigung und Desinfektion von Kontaktlinsen mittels Kombinationen von polymeren quaternären Ammoniumverbindungen und Enzymen
ES2103987T3 (es) Usos de acidos grasos alfa-hidroxilados.
ATE62818T1 (de) Desinfektions- und reinigungsmittelsystem fuer kontaktlinsen.
DK0472327T3 (da) Præparat på form af øjendråber
IL84911A (en) Processes for the preparation of collagen products, and pharmaceutical compositions containing the same
NO175406C (no) Fremgangsmåte ved fremstilling av piroxam i vandig opplösning
TW266154B (de)
ATE132753T1 (de) Mittel zur verhütung von infektionen mit methicillin-beständigem staphylococcus
KR930000096A (ko) 제제
ATE65401T1 (de) Stabile, injizierbare loesungen von salzen von vincristin.
ES2117633T3 (es) Producto lacteo liquido y procedimiento de preparacion.
DE69416764D1 (de) Verfahren zur Stabilisierung eines Kontaktlinsenpräparats
FR2646603B1 (fr) Composition nettoyante
KR930001903A (ko) 유비데카레논 경구용 수용액 제제
SE9302203D0 (sv) Composition for ophthalmic use
IE800070L (en) Treatment of contact lenses
CA2114747A1 (en) Method for Stabilizing an Agent for Contact Lenses
DE69115890D1 (de) Sterilisierende zusammensetzung
IT1247752B (it) Composizioni farmaceutiche aventi come principio attivo calcitonina da somministrarsi per via intranasale.
JPS57116009A (en) Composition for injection

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee